إعلان مُمول
Emerging Biomarkers in Idiopathic Pulmonary Fibrosis Management
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive interstitial lung disease defined by irreversible scarring of lung tissue. While it has long presented challenges due to late diagnosis and limited treatment options, recent clinical advances and heightened awareness are shifting the treatment paradigm. As novel antifibrotic therapies evolve and precision approaches become integrated...
0 التعليقات 0 المشاركات 57 مشاهدة 0 معاينة
إعلان مُمول
إعلان مُمول
إعلان مُمول